213 related articles for article (PubMed ID: 17669555)
1. The synaptic and nonsynaptic glycine transporter type-1 inhibitors Org-24461 and NFPS alter single neuron firing rate in the rat dorsal raphe nucleus. Further evidence for a glutamatergic-serotonergic interaction and its role in antipsychotic action.
Papp A; Juranyi Z; Nagymajtenyi L; Matyus P; Harsing LG
Neurochem Int; 2008 Jan; 52(1-2):130-4. PubMed ID: 17669555
[TBL] [Abstract][Full Text] [Related]
2. AMPA and NMDA receptor regulation of firing activity in 5-HT neurons of the dorsal and median raphe nuclei.
Gartside SE; Cole AJ; Williams AP; McQuade R; Judge SJ
Eur J Neurosci; 2007 May; 25(10):3001-8. PubMed ID: 17509083
[TBL] [Abstract][Full Text] [Related]
3. Effects of histamine, H1- and H2-receptor antagonists on the activity of serotonergic neurons in the dorsal raphe nucleus.
Lakoski JM; Aghajanian GK
J Pharmacol Exp Ther; 1983 Nov; 227(2):517-23. PubMed ID: 6138428
[TBL] [Abstract][Full Text] [Related]
4. Positive N-methyl-D-aspartate receptor modulation by selective glycine transporter-1 inhibition in the rat dorsal spinal cord in vivo.
Whitehead KJ; Pearce SM; Walker G; Sundaram H; Hill D; Bowery NG
Neuroscience; 2004; 126(2):381-90. PubMed ID: 15207356
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex.
Konradsson A; Marcus MM; Hertel P; Svensson TH; Jardemark KE
Synapse; 2006 Aug; 60(2):102-8. PubMed ID: 16715496
[TBL] [Abstract][Full Text] [Related]
6. 5,7-dihydroxytryptamine lesion of the dorsal raphe nucleus alters neuronal activity of the subthalamic nucleus in normal and 6-hydroxydopamine-lesioned rats.
Liu J; Chu YX; Zhang QJ; Wang S; Feng J; Li Q
Brain Res; 2007 May; 1149():216-22. PubMed ID: 17376410
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 inhibits firing of serotonergic neurons in the dorsal raphe nucleus and enhances GABAergic inhibitory post-synaptic potentials.
Brambilla D; Franciosi S; Opp MR; Imeri L
Eur J Neurosci; 2007 Oct; 26(7):1862-9. PubMed ID: 17868373
[TBL] [Abstract][Full Text] [Related]
8. The orexinergic synaptic innervation of serotonin- and orexin 1-receptor-containing neurons in the dorsal raphe nucleus.
Wang QP; Koyama Y; Guan JL; Takahashi K; Kayama Y; Shioda S
Regul Pept; 2005 Mar; 126(1-2):35-42. PubMed ID: 15620411
[TBL] [Abstract][Full Text] [Related]
9. Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter-1 (GlyT1).
Manahan-Vaughan D; Wildförster V; Thomsen C
Eur J Neurosci; 2008 Oct; 28(7):1342-50. PubMed ID: 18973561
[TBL] [Abstract][Full Text] [Related]
10. Expression of serotonin 5-HT2C receptors in GABAergic cells of the anterior raphe nuclei.
Serrats J; Mengod G; Cortés R
J Chem Neuroanat; 2005 Mar; 29(2):83-91. PubMed ID: 15652696
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons.
Higuchi M; Suzuki Y; Yatani Y; Kitagawa Y; Nagayasu K; Shirakawa H; Nakagawa T; Kaneko S
J Neurochem; 2008 Sep; 106(6):2410-20. PubMed ID: 18662325
[TBL] [Abstract][Full Text] [Related]
12. Transmembrane domains 1 and 3 of the glycine transporter GLYT1 contain structural determinants of N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)-propyl]sarcosine specificity.
Núñez E; Martínez-Maza R; Geerlings A; Aragón C; López-Corcuera B
Neuropharmacology; 2005 Nov; 49(6):922-34. PubMed ID: 16143353
[TBL] [Abstract][Full Text] [Related]
13. Evidence for serotonin synthesis-dependent regulation of in vitro neuronal firing rates in the midbrain raphe complex.
Evans AK; Reinders N; Ashford KA; Christie IN; Wakerley JB; Lowry CA
Eur J Pharmacol; 2008 Aug; 590(1-3):136-49. PubMed ID: 18577382
[TBL] [Abstract][Full Text] [Related]
14. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat.
Wang S; Zhang QJ; Liu J; Wu ZH; Wang T; Gui ZH; Chen L; Wang Y
Neuroscience; 2009 Mar; 159(2):850-61. PubMed ID: 19174182
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
[TBL] [Abstract][Full Text] [Related]
16. Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain.
El Mansari M; Ghanbari R; Janssen S; Blier P
Neuropharmacology; 2008 Dec; 55(7):1191-8. PubMed ID: 18708076
[TBL] [Abstract][Full Text] [Related]
17. Serotonergic neuronal activity in the dorsal raphe nucleus of selectively bred alcohol-preferring and alcohol-nonpreferring rats and unselected wistar rats.
Morzorati SL; Johnson TB
Alcohol Clin Exp Res; 1999 Aug; 23(8):1362-7. PubMed ID: 10470979
[TBL] [Abstract][Full Text] [Related]
18. Role of glutamatergic receptors located in the nucleus raphe magnus on antinociceptive effect of morphine microinjected into the nucleus cuneiformis of rat.
Haghparast A; Soltani-Hekmat A; Khani A; Komaki A
Neurosci Lett; 2007 Oct; 427(1):44-9. PubMed ID: 17920194
[TBL] [Abstract][Full Text] [Related]
19. Involvement of medullary GABAergic and serotonergic raphe neurons in respiratory control: electrophysiological and immunohistochemical studies in rats.
Cao Y; Matsuyama K; Fujito Y; Aoki M
Neurosci Res; 2006 Nov; 56(3):322-31. PubMed ID: 16962678
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areas.
Perry KW; Falcone JF; Fell MJ; Ryder JW; Yu H; Love PL; Katner J; Gordon KD; Wade MR; Man T; Nomikos GG; Phebus LA; Cauvin AJ; Johnson KW; Jones CK; Hoffmann BJ; Sandusky GE; Walter MW; Porter WJ; Yang L; Merchant KM; Shannon HE; Svensson KA
Neuropharmacology; 2008 Oct; 55(5):743-54. PubMed ID: 18602930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
